» Articles » PMID: 35838899

Effect of Maternal Pregestational Diabetes Mellitus on Congenital Heart Diseases

Overview
Journal World J Pediatr
Specialty Pediatrics
Date 2022 Jul 15
PMID 35838899
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increasing population of diabetes mellitus in adolescent girls and women of childbearing age contributes to a large number of pregnancies with maternal pregestational diabetes mellitus. Congenital heart diseases are a common adverse outcome in mothers with pregestational diabetes mellitus. However, there is little systematic information between maternal pregestational diabetes mellitus and congenital heart diseases in the offspring.

Data Sources: Literature selection was performed in PubMed. One hundred and seven papers were cited in our review, including 36 clinical studies, 26 experimental studies, 31 reviews, eight meta-analysis articles, and six of other types.

Results: Maternal pregestational diabetes mellitus poses a high risk of congenital heart diseases in the offspring and causes variety of phenotypes of congenital heart diseases. Factors such as persistent maternal hyperglycemia, oxidative stress, polymorphism of uncoupling protein 2, polymorphism of adiponectin gene, Notch 1 pathway, Nkx2.5 disorders, dysregulation of the hypoxia-inducible factor 1, and viral etiologies are associated with the occurrence of congenital heart diseases in the offspring of mothers with pregestational diabetes mellitus. Treatment options including blood sugar-reducing, anti-oxidative stress drug supplements and exercise can help to prevent maternal pregestational diabetes mellitus from inducing congenital heart diseases.

Conclusions: Our review contributes to a better understanding of the association between maternal pregestational diabetes mellitus and congenital heart diseases in the offspring and to a profound thought of the mechanism, preventive and therapeutic measurements of congenital heart diseases caused by maternal pregestational diabetes mellitus.

Citing Articles

Association of congenital heart defects (CHD) with factors related to maternal health and pregnancy in newborns in Puerto Rico.

Delgado Y, Gaytan C, Perez N, Miranda E, Morales B, Santos M Congenit Heart Dis. 2024; 19(1):19-31.

PMID: 38912385 PMC: 11192526. DOI: 10.32604/chd.2024.046339.


Tergitol Based Decellularization Protocol Improves the Prerequisites for Pulmonary Xenografts: Characterization and Biocompatibility Assessment.

Tondato S, Moro A, Butt S, Todesco M, Sandrin D, Borile G Polymers (Basel). 2023; 15(4).

PMID: 36850103 PMC: 9967102. DOI: 10.3390/polym15040819.

References
1.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

2.
Zimmet P, Magliano D, Herman W, Shaw J . Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014; 2(1):56-64. DOI: 10.1016/S2213-8587(13)70112-8. View

3.
Mayer-Davis E, Dabelea D, Lawrence J . Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med. 2017; 377(3):301. PMC: 5639715. DOI: 10.1056/NEJMc1706291. View

4.
Menke A, Casagrande S, Cowie C . Contributions of A1c, fasting plasma glucose, and 2-hour plasma glucose to prediabetes prevalence: NHANES 2011-2014. Ann Epidemiol. 2018; 28(10):681-685.e2. DOI: 10.1016/j.annepidem.2018.07.012. View

5.
Andes L, Cheng Y, Rolka D, Gregg E, Imperatore G . Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016. JAMA Pediatr. 2019; 174(2):e194498. PMC: 6902249. DOI: 10.1001/jamapediatrics.2019.4498. View